These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Deferoxamine for the treatment of hemosiderosis during CAPD.
    Author: Gomez RA, Campbell F, Savory J, Chevalier RL.
    Journal: Int J Pediatr Nephrol; 1987; 8(1):21-4. PubMed ID: 3583552.
    Abstract:
    The effects of chelation therapy by intravenous and intraperitoneal administration of deferoxamine were compared during maintenance continuous ambulatory peritoneal dialysis (CAPD) in a child with end stage renal disease and hemosiderosis. We demonstrate that intraperitoneally administered deferoxamine is safer, more practical and efficient than weekly intravenously administered deferoxamine for the treatment of iron overload in the pediatric patient undergoing CAPD.
    [Abstract] [Full Text] [Related] [New Search]